244 related articles for article (PubMed ID: 26426095)
1. Outcome and Prognostic Factors for Canine Splenic Lymphoma Treated by Splenectomy (1995-2011).
van Stee LL; Boston SE; Singh A; Romanelli G; Rubio-Guzman A; Scase TJ
Vet Surg; 2015 Nov; 44(8):976-82. PubMed ID: 26426095
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
3. Use of splenectomy in the management of lymphoma in dogs: 16 cases (1976-1985).
Brooks MB; Matus RE; Leifer CE; Patnaik AK
J Am Vet Med Assoc; 1987 Oct; 191(8):1008-10. PubMed ID: 3679980
[TBL] [Abstract][Full Text] [Related]
4. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma.
O'Brien D; Moore PF; Vernau W; Peauroi JR; Rebhun RB; Rodriguez CO; Skorupski KA
J Vet Intern Med; 2013; 27(4):949-54. PubMed ID: 23734665
[TBL] [Abstract][Full Text] [Related]
6. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy.
Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N
J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268
[TBL] [Abstract][Full Text] [Related]
8. Nonangiogenic and nonlymphomatous sarcomas of the canine spleen: 57 cases (1975-1987).
Weinstein MJ; Carpenter JL; Schunk CJ
J Am Vet Med Assoc; 1989 Sep; 195(6):784-8. PubMed ID: 2551865
[TBL] [Abstract][Full Text] [Related]
9. Complications and short-term outcomes associated with single-port laparoscopic splenectomy in dogs.
Mayhew PD; Sutton JS; Singh A; Runge JJ; Case JB; Griffin MA; Giuffrida MA
Vet Surg; 2018 Jun; 47(S1):O67-O74. PubMed ID: 29178506
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors for dogs with a histological diagnosis of splenic hematoma following splenectomy: 35 cases (2001-2013).
Patten SG; Boston SE; Monteith GJ
Can Vet J; 2016 Aug; 57(8):842-6. PubMed ID: 27493283
[TBL] [Abstract][Full Text] [Related]
11. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
[TBL] [Abstract][Full Text] [Related]
12. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of malignancy and factors affecting outcome of cats undergoing splenectomy.
Rossanese M; Williams H; Puerta B; Scott P; Chanoit G; Guillén A
J Am Vet Med Assoc; 2023 Nov; 261(11):1646-1652. PubMed ID: 37582488
[TBL] [Abstract][Full Text] [Related]
15. Incidence of malignancy and outcomes for dogs undergoing splenectomy for incidentally detected nonruptured splenic nodules or masses: 105 cases (2009-2013).
Cleveland MJ; Casale S
J Am Vet Med Assoc; 2016 Jun; 248(11):1267-73. PubMed ID: 27172343
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic-assisted splenectomy in dogs: 18 cases (2012-2014).
Wright T; Singh A; Mayhew PD; Runge JJ; Brisson BA; Oblak ML; Case JB
J Am Vet Med Assoc; 2016 Apr; 248(8):916-22. PubMed ID: 27031418
[TBL] [Abstract][Full Text] [Related]
18. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
19. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
[TBL] [Abstract][Full Text] [Related]
20. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
